L. Mignot

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

Cora N. Sternberg, Iwona Skoneczna, J. Martijn Kerst et al. · The Lancet Oncology · 2014 · 381 citations

Radical Cystectomy, Urology, Surgical Oncology +7

Phase I study of oxaliplatin in patients with advanced cancer

Jean Marc Extra, Marc Espié, Fabien Calvo et al. · Cancer Chemotherapy and Pharmacology · 1990 · 338 citations

Advanced Cancer, Medicine, Cancer Management +6

High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients

Jean‐Yves Pierga, David Hajage, Thomas Bachelot et al. · Annals of Oncology · 2011 · 269 citations · Full text

Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up

Nicolas Penel, Axel Le Cesne, B. Bui et al. · Annals of Oncology · 2010 · 229 citations · Full text

Medicine, Fnclcc/french Sarcoma Group, Pathology +5

Does a Geriatric Oncology Consultation Modify the Cancer Treatment Plan for Elderly Patients?

V. Girre, Marie-Christine Falcou, Mathilde Gisselbrecht et al. · The Journals of Gerontology Series A · 2008 · 192 citations · Full text